Skip metastasis in papillary thyroid carcinoma is difficult to predict in clinical practice

BMC Cancer

Table 4 Univariate analysis results for skip metastasis (203 patients)

Characteristics		Skip negative	Skip positive	Total	Skip rate(%)	p-value
Gender	Female	128	24	152	15.79	0.483
Gender	Male	45	6	51	11.76
Age(year)	≤25	19	0	19	0	0.065
	25–35	36	5	41	12.2
	35–45	54	10	64	15.63
	45–55	41	8	49	16.33
	55–65	13	6	19	31.58
	>65	10	1	11	9.09
Age(year)	≤45	109	15	124	12.1	0.177
Age(year)	>45	64	15	79	18.99
Size(cm)	≤0.5	4	6	10	60	0.001*
	0.5–1	39	5	44	11.36
	1–1.5	35	5	40	12.5
	1.5–2	26	6	32	18.75
	>2	69	8	77	10.39
Tumor Spread	Absent	132	27	159	16.98	0.147
Tumor Spread	Present	41	3	44	6.82
Psammoma bodies	Absent	166	29	195	14.87	1
Psammoma bodies	Present	7	1	8	12.5
Multifocality	Single	151	28	179	15.64	0.541
Multifocality	Multi	22	2	24	8.33
ETE	None	109	18	127	14.17	0.753
ETE	ETE	64	12	76	15.79
Location	Upper	80	19	99	19.19	0.387
	Middle	56	7	63	11.11
	Inferior	18	2	20	10.00
	Whole	19	2	21	9.52
Location Upper	Upper	80	19	99	19.19	0.084
Location Upper	None	93	11	104	10.58

*symbol for p < 0.05; ETE extrathyroid extension, CLNM central lymph node metastases, LLNM lateral lymph node metastasis

ISSN: 1471-2407